{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30431140", "DateCompleted": {"Year": "2019", "Month": "01", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "11", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.3892/or.2018.6864"], "Journal": {"ISSN": "1791-2431", "JournalIssue": {"Volume": "41", "Issue": "2", "PubDate": {"Year": "2019", "Month": "Feb"}}, "Title": "Oncology reports", "ISOAbbreviation": "Oncol Rep"}, "ArticleTitle": "Reactive oxygen species induced by icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells.", "Pagination": {"StartPage": "765", "EndPage": "778", "MedlinePgn": "765-778"}, "Abstract": {"AbstractText": ["Increased production of reactive oxygen species (ROS) is a distinct feature of various types of cancer. ROS drive tumor progression and render cancer cells vulnerable to additional oxidative insult. The various natural herb compounds have been shown to induce additional production of ROS in cancer cells, although the physiological implications of ROS under these conditions are not fully determined. In the present study, icaritin, a natural compound derived from the medicinal plants Epimedium, was demonstrated to potently suppresses the proliferation of human HeLa and SiHa cervical cancer cells, without similar affects on non-cancerous CCD\u20111095Sk fibroblasts and 293\u00a0cells, as measured by MTT and colony formation assays. Icaritin treatment caused a rapid increase in ROS in HeLa and SiHa cells, which was followed by a prominent increase in the number of DNA strand breaks. Consequently, the levels of the pro\u2011apoptotic protein Bax and activated caspase\u00a03 and 9 enzymes were increased, while the levels of the anti\u2011apoptotic proteins Bcl\u20112 and XIAP were downregulated. These protein expression changes were accompanied by marked induction of apoptosis in icaritin\u2011treated cancer cells. The results suggested that the icaritin\u2011induced ROS overload promoted cancer cell death via induction of extensive oxidative DNA damage, which subsequently resulted in large numbers of DNA strand breaks and the activation of the intrinsic apoptotic pathway."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathogenobiology, The Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medicine, Jilin University, Changchun, Jilin 130021, P.R. China."}], "LastName": "Chen", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China."}], "LastName": "Song", "ForeName": "Liyan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China."}], "LastName": "Hou", "ForeName": "Yuefang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathogenobiology, The Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medicine, Jilin University, Changchun, Jilin 130021, P.R. China."}], "LastName": "Li", "ForeName": "Fan", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Oncol Rep", "NlmUniqueID": "9422756", "ISSNLinking": "1021-335X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}, {"RegistryNumber": "UFE666UELY", "NameOfSubstance": "icaritin"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "DNA"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Breaks"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Epimedium"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Fibroblasts"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": [], "DescriptorName": "HeLa Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Uterine Cervical Neoplasms"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Dancey JE, Bedard PL, Onetto N, Hudson TJ. The genetic basis for cancer treatment decisions. Cell. 2012;148:409\u2013420. doi: 10.1016/j.cell.2012.01.014.", "ArticleIdList": ["10.1016/j.cell.2012.01.014", "22304912"]}, {"Citation": "Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015;(35 Suppl):S276\u2013S304. doi: 10.1016/j.semcancer.2015.09.007.", "ArticleIdList": ["10.1016/j.semcancer.2015.09.007", "PMC4819002", "26590477"]}, {"Citation": "Hu X, Zhang Z. Understanding the genetic mechanisms of cancer drug resistance using genomic approaches. Trends Genet. 2016;32:127\u2013137. doi: 10.1016/j.tig.2015.11.003.", "ArticleIdList": ["10.1016/j.tig.2015.11.003", "26689126"]}, {"Citation": "Zecchini V, Frezza C. Metabolic synthetic lethality in cancer therapy. Biochim Biophys Acta. 2017;1858:723\u2013731. doi: 10.1016/j.bbabio.2016.12.003.", "ArticleIdList": ["10.1016/j.bbabio.2016.12.003", "27956047"]}, {"Citation": "Fece de la Cruz F, Gapp BV, Nijman SM. Synthetic lethal vulnerabilities of cancer. Annu Rev Pharmacol Toxicol. 2015;55:513\u2013531. doi: 10.1146/annurev-pharmtox-010814-124511.", "ArticleIdList": ["10.1146/annurev-pharmtox-010814-124511", "25340932"]}, {"Citation": "Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23:27\u201347. doi: 10.1016/j.cmet.2015.12.006.", "ArticleIdList": ["10.1016/j.cmet.2015.12.006", "PMC4715268", "26771115"]}, {"Citation": "Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50\u201364. doi: 10.1016/j.semcdb.2017.05.023.", "ArticleIdList": ["10.1016/j.semcdb.2017.05.023", "28587975"]}, {"Citation": "Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24:R453\u2013R462. doi: 10.1016/j.cub.2014.03.034.", "ArticleIdList": ["10.1016/j.cub.2014.03.034", "PMC4055301", "24845678"]}, {"Citation": "Rudd SG, Valerie NCK, Helleday T. Pathways controlling dNTP pools to maintain genome stability. DNA Repair. 2016;44:193\u2013204. doi: 10.1016/j.dnarep.2016.05.032.", "ArticleIdList": ["10.1016/j.dnarep.2016.05.032", "27311542"]}, {"Citation": "Rai P, Onder TT, Young JJ, McFaline JL, Pang B, Dedon PC, Weinberg RA. Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. Proc Natl Acad Sci USA. 2009;106:169\u2013174. doi: 10.1073/pnas.0809834106.", "ArticleIdList": ["10.1073/pnas.0809834106", "PMC2629241", "19118192"]}, {"Citation": "Huang X, Zhu D, Lou Y. A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells. Eur J Pharmacol. 2007;564:26\u201336. doi: 10.1016/j.ejphar.2007.02.039.", "ArticleIdList": ["10.1016/j.ejphar.2007.02.039", "17382317"]}, {"Citation": "Indran IR, Liang RL, Min TE, Yong EL. Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health. Pharmacol Ther. 2016;162:188\u2013205. doi: 10.1016/j.pharmthera.2016.01.015.", "ArticleIdList": ["10.1016/j.pharmthera.2016.01.015", "26820757"]}, {"Citation": "Tan HL, Chan KG, Pusparajah P, Saokaew S, Duangjai A, Lee LH, Goh BH. Anti-cancer properties of the naturally occurring aphrodisiacs: Icariin and its derivatives. Front Pharmacol. 2016;7:191. doi: 10.3389/fphar.2016.00191.", "ArticleIdList": ["10.3389/fphar.2016.00191", "PMC4925704", "27445824"]}, {"Citation": "Wang ZQ, Lou YJ. Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. Eur J Pharmacol. 2004;504:147\u2013153. doi: 10.1016/j.ejphar.2004.10.002.", "ArticleIdList": ["10.1016/j.ejphar.2004.10.002", "15541416"]}, {"Citation": "Zhu DY, Lou YJ. Inducible effects of icariin, icaritin, and desmethylicaritin on directional differentiation of embryonic stem cells into cardiomyocytes in vitro. Acta Pharmacol Sin. 2005;26:477\u2013485. doi: 10.1111/j.1745-7254.2005.00076.x.", "ArticleIdList": ["10.1111/j.1745-7254.2005.00076.x", "15780198"]}, {"Citation": "Tsang WP, Zhang F, He Q, Cai W, Huang J, Chan WY, Shen Z, Wan C. Icaritin enhances mESC self-renewal through upregulating core pluripotency transcription factors mediated by ER\u03b1. Sci Rep. 2017;7:40894. doi: 10.1038/srep40894.", "ArticleIdList": ["10.1038/srep40894", "PMC5238509", "28091581"]}, {"Citation": "Wang Z, Zhang X, Wang H, Qi L, Lou Y. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience. 2007;145:911\u2013922. doi: 10.1016/j.neuroscience.2006.12.059.", "ArticleIdList": ["10.1016/j.neuroscience.2006.12.059", "17321691"]}, {"Citation": "Ma HR, Wang J, Chen YF, Chen H, Wang WS, Aisa HA. Icariin and icaritin stimulate the proliferation of SKBr3 cells through the GPER1-mediated modulation of the EGFR-MAPK signaling pathway. Int J Mol Med. 2014;33:1627\u20131634. doi: 10.3892/ijmm.2014.1722.", "ArticleIdList": ["10.3892/ijmm.2014.1722", "24718680"]}, {"Citation": "Zhang XT, Kang LG, Ding L, Vranic S, Gatalica Z, Wang ZY. A positive feedback loop of ER-\u03b136/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene. 2010;30:770\u2013780. doi: 10.1038/onc.2010.458.", "ArticleIdList": ["10.1038/onc.2010.458", "PMC3020987", "20935677"]}, {"Citation": "Omarjee S, Jacquemetton J, Poulard C, Rochel N, Dejaegere A, Chebaro Y, Treilleux I, Marangoni E, Corbo L, Romancer ML. The molecular mechanisms underlying the ER\u03b1-36-mediated signaling in breast cancer. Oncogene. 2017;36:2503\u20132514. doi: 10.1038/onc.2016.415.", "ArticleIdList": ["10.1038/onc.2016.415", "PMC5422711", "27941878"]}, {"Citation": "Thiebaut C, Chamard-Jovenin C, Chesnel A, Morel C, Djermoune EH, Boukhobza T, Dumond H. Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression. PLoS One. 2017;12:e0173931. doi: 10.1371/journal.pone.0173931.", "ArticleIdList": ["10.1371/journal.pone.0173931", "PMC5354400", "28301550"]}, {"Citation": "Wang X, Zheng N, Dong J, Wang X, Liu L, Huang J. Estrogen receptor-\u03b136 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells. J Steroid Biochem Mol Biol. 2017;171:318\u2013327. doi: 10.1016/j.jsbmb.2017.05.009.", "ArticleIdList": ["10.1016/j.jsbmb.2017.05.009", "28529129"]}, {"Citation": "Chen M, Turhan AG, Ding H, Lin Q, Meng K, Jiang X. Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex. Oncotarget. 2017;8:43662\u201343677.", "ArticleIdList": ["PMC5546432", "28599273"]}, {"Citation": "Tiong CT, Chen C, Zhang SJ, Li J, Soshilov A, Denison MS, Lee LS, Tam VH, Wong SP, Xu HE, et al. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ER\u03b1 protein. Carcinogenesis. 2012;33:1089\u20131097. doi: 10.1093/carcin/bgs110.", "ArticleIdList": ["10.1093/carcin/bgs110", "PMC3334513", "22345291"]}, {"Citation": "Sun F, Indran IR, Zhang ZW, Tan MH, Li Y, Lim ZL, Hua R, Yang C, Soon FF, Li J, et al. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants. Carcinogenesis. 2015;36:757\u2013768. doi: 10.1093/carcin/bgv040.", "ArticleIdList": ["10.1093/carcin/bgv040", "PMC4580537", "25908644"]}, {"Citation": "He J, Wang Y, Duan F, Jiang H, Chen MF, Tang SY. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor. Planta Med. 2010;76:1834\u20131839. doi: 10.1055/s-0030-1250042.", "ArticleIdList": ["10.1055/s-0030-1250042", "20560114"]}, {"Citation": "Zhu JF, Li ZJ, Zhang GS, Meng K, Kuang WY, Li J, Zhou XF, Li RJ, Peng HL, Dai CW, et al. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings. PLoS One. 2011;6:e23720. doi: 10.1371/journal.pone.0023720.", "ArticleIdList": ["10.1371/journal.pone.0023720", "PMC3161749", "21887305"]}, {"Citation": "Yang JG, Lu R, Ye XJ, Zhang J, Tan YQ, Zhou G. Icaritin reduces oral squamous cell carcinoma progression via the inhibition of STAT3 signaling. Int J Mol Sci. 2017;18:E132. doi: 10.3390/ijms18010132.", "ArticleIdList": ["10.3390/ijms18010132", "PMC5297765", "28085115"]}, {"Citation": "Li S, Priceman SJ, Xin H, Zhang W, Deng J, Liu Y, Huang J, Zhu W, Chen M, Hu W, et al. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma. PLoS One. 2013;8:e81657. doi: 10.1371/journal.pone.0081657.", "ArticleIdList": ["10.1371/journal.pone.0081657", "PMC3855768", "24324713"]}, {"Citation": "Zhu S, Wang Z, Li Z, Peng H, Luo Y, Deng M, Li R, Dai C, Xu Y, Liu S, et al. Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3. Oncotarget. 2015;6:10460\u201310472. doi: 10.18632/oncotarget.3399.", "ArticleIdList": ["10.18632/oncotarget.3399", "PMC4496367", "25865044"]}, {"Citation": "Guo Y, Zhang X, Meng J, Wang ZY. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. Eur J Pharmacol. 2011;658:114\u2013122. doi: 10.1016/j.ejphar.2011.02.005.", "ArticleIdList": ["10.1016/j.ejphar.2011.02.005", "PMC3071461", "21376032"]}, {"Citation": "Tong JS, Zhang QH, Huang X, Fu XQ, Qi ST, Wang YP, Hou Y, Sheng J, Sun QY. Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PLoS One. 2011;6:e16781. doi: 10.1371/journal.pone.0016781.", "ArticleIdList": ["10.1371/journal.pone.0016781", "PMC3050810", "21408143"]}, {"Citation": "Li Q, Huai L, Zhang C, Wang C, Jia Y, Chen Y, Yu P, Wang H, Rao Q, Wang M, et al. Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways. Int J Hematol. 2013;97:617\u2013623. doi: 10.1007/s12185-013-1317-9.", "ArticleIdList": ["10.1007/s12185-013-1317-9", "23550021"]}, {"Citation": "Li Z, Meng X, Jin L. Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells. Am J Transl Res. 2016;8:4628\u20134643.", "ArticleIdList": ["PMC5126309", "27904667"]}, {"Citation": "Wo YB, Zhu DY, Hu Y, Wang ZQ, Liu J, Lou YJ. Reactive oxygen species involved in prenylflavonoids, icariin and icaritin, initiating cardiac differentiation of mouse embryonic stem cells. J Cell Biochem. 2008;103:1536\u20131550. doi: 10.1002/jcb.21541.", "ArticleIdList": ["10.1002/jcb.21541", "17985362"]}, {"Citation": "Li C, Peng W, Song X, Wang Q, Wang W. Anticancer effect of icaritin inhibits cell growth of colon cancer through reactive oxygen species, Bcl-2 and cyclin D1/E signaling. Oncol Lett. 2016;12:3537\u20133542. doi: 10.3892/ol.2016.5089.", "ArticleIdList": ["10.3892/ol.2016.5089", "PMC5103982", "27900033"]}, {"Citation": "Song J, Shu L, Zhang Z, Tan X, Sun E, Jin X, Chen Y, Jia X. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Chem Biol Interact. 2012;199:9\u201317. doi: 10.1016/j.cbi.2012.05.005.", "ArticleIdList": ["10.1016/j.cbi.2012.05.005", "22687635"]}, {"Citation": "Zheng Q, Liu WW, Li B, Chen HJ, Zhu WS, Yang GX, Chen MJ, He GY. Anticancer effect of icaritin on human lung cancer cells through inducing S phase cell cycle arrest and apoptosis. J Huazhong Univ Sci Technol Med Sci. 2014;34:497\u2013503. doi: 10.1007/s11596-014-1305-1.", "ArticleIdList": ["10.1007/s11596-014-1305-1", "25135717"]}, {"Citation": "Musa J, Achenbach CJ, O'Dwyer LC, Evans CT, McHugh M, Hou L, Simon MA, Murphy RL, Jordan N. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis. PLoS One. 2017;12:e0183924. doi: 10.1371/journal.pone.0183924.", "ArticleIdList": ["10.1371/journal.pone.0183924", "PMC5584806", "28873092"]}, {"Citation": "Ding Y, Wang H, Niu J, Luo M, Gou Y, Miao L, Zou Z, Cheng Y. Induction of ROS overload by alantolactone prompts oxidative DNA damage and apoptosis in colorectal cancer cells. Int J Mol Sci. 2016;17:558. doi: 10.3390/ijms17040558.", "ArticleIdList": ["10.3390/ijms17040558", "PMC4849014", "27089328"]}, {"Citation": "Dong L, Wang H, Niu J, Zou M, Wu N, Yu D, Wang Y, Zou Z. Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1. Onco Targets Ther. 2015;8:3649\u20133664.", "ArticleIdList": ["PMC4677763", "26677335"]}, {"Citation": "Yazinski SA, Zou L. Functions, regulation, and therapeutic implications of the ATR checkpoint pathway. Annu Rev Genet. 2016;50:155\u2013173. doi: 10.1146/annurev-genet-121415-121658.", "ArticleIdList": ["10.1146/annurev-genet-121415-121658", "27617969"]}, {"Citation": "Jin L, Miao J, Liu Y, Li X, Jie Y, Niu Q, Han X. Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells. Biomed Pharmacother. 2017;85:287\u2013295. doi: 10.1016/j.biopha.2016.11.023.", "ArticleIdList": ["10.1016/j.biopha.2016.11.023", "27889233"]}, {"Citation": "Pagliara V, Saide A, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Russo G, Russo A. 5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-\u03b2-synthase in colon cancer cells lacking p53. Oncotarget. 2016;7:50333\u201350348. doi: 10.18632/oncotarget.10385.", "ArticleIdList": ["10.18632/oncotarget.10385", "PMC5226586", "27385096"]}, {"Citation": "Russo A, Saide A, Cagliani R, Cantile M, Botti G, Russo G. rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NF\u03baB upon 5-FU treatment. Sci Rep. 2016;6:38369. doi: 10.1038/srep38369.", "ArticleIdList": ["10.1038/srep38369", "PMC5141482", "27924828"]}, {"Citation": "Russo A, Saide A, Smaldone S, Faraonio R, Russo G. Role of uL3 in multidrug resistance in p53-mutated lung cancer cells. Int J Mol Sci. 2017;18:E547. doi: 10.3390/ijms18030547.", "ArticleIdList": ["10.3390/ijms18030547", "PMC5372563", "28273808"]}]}], "History": [{"Year": "2018", "Month": "3", "Day": "17"}, {"Year": "2018", "Month": "10", "Day": "8"}, {"Year": "2018", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "12"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30431140", "PMC6312933", "10.3892/or.2018.6864"]}}]}